NM_005216.5:c.599G>A
Variant names:
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_005216.5(DDOST):c.599G>A(p.Gly200Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000708 in 1,412,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )
Consequence
DDOST
NM_005216.5 missense
NM_005216.5 missense
Scores
7
11
1
Clinical Significance
Conservation
PhyloP100: 7.77
Publications
7 publications found
Genes affected
DDOST (HGNC:2728): (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit) This gene encodes a component of the oligosaccharyltransferase complex which catalyzes the transfer of high-mannose oligosaccharides to asparagine residues on nascent polypeptides in the lumen of the rough endoplasmic reticulum. The protein complex co-purifies with ribosomes. The product of this gene is also implicated in the processing of advanced glycation endproducts (AGEs), which form from non-enzymatic reactions between sugars and proteins or lipids and are associated with aging and hyperglycemia. [provided by RefSeq, Jul 2008]
DDOST Gene-Disease associations (from GenCC):
- DDOST-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.914
PP5
Variant 1-20654660-C-T is Pathogenic according to our data. Variant chr1-20654660-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 30246.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDOST | NM_005216.5 | c.599G>A | p.Gly200Asp | missense_variant | Exon 6 of 11 | ENST00000602624.7 | NP_005207.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDOST | ENST00000602624.7 | c.599G>A | p.Gly200Asp | missense_variant | Exon 6 of 11 | 1 | NM_005216.5 | ENSP00000473655.2 | ||
DDOST | ENST00000415136.6 | c.650G>A | p.Gly217Asp | missense_variant | Exon 6 of 11 | 1 | ENSP00000399457.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.08e-7 AC: 1AN: 1412772Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 698090 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1412772
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
698090
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32298
American (AMR)
AF:
AC:
0
AN:
37938
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25350
East Asian (EAS)
AF:
AC:
0
AN:
37094
South Asian (SAS)
AF:
AC:
0
AN:
80248
European-Finnish (FIN)
AF:
AC:
0
AN:
50008
Middle Eastern (MID)
AF:
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1085606
Other (OTH)
AF:
AC:
0
AN:
58520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital disorder of glycosylation type Ir Pathogenic:1
Feb 10, 2012
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
not provided Pathogenic:1
May 14, 2014
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;T;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;M
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;.;D
REVEL
Pathogenic
Sift
Uncertain
.;.;D
Sift4G
Uncertain
D;D;D
Polyphen
P;.;P
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0522);.;Gain of relative solvent accessibility (P = 0.0522);
MVP
MPC
0.81
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.